Screener
Krystal Biotech, Inc. KRYS Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except par value) | March 31,2026 | December 31,2025 |
|---|---|---|
| Long-term investments | 193,485 | 128,066 |
| Right-of-use assets | 7,035 | 7,239 |
| Deferred tax asset, net of valuation allowance | 22,824 | 22,824 |
| Other non-current assets | 300 | 287 |
| Total assets | $1,396,967 | $1,333,794 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $4,089 | $3,238 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s other non-current assets?
- Krystal Biotech, Inc. (KRYS) reported other non-current assets of $300K in Q1 2026.
- How has Krystal Biotech, Inc.'s other non-current assets changed year-over-year?
- Krystal Biotech, Inc.'s other non-current assets increased by 37.6% year-over-year, from $218K to $300K.
- What is the long-term trend for Krystal Biotech, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s other non-current assets has grown at a -29.2% compound annual growth rate (CAGR), from $1.61M to $287K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Krystal Biotech, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude